Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
GSPI and Abridge Build Development Bridge to India Global Pharmaceutical Services Inc (GSPI), a Kalamazoo, MI-based provider of research and development support, has entered into a partnership with Abridge Clinical Research, a research and development company located in Mumbai, India. The partnership, which essentially creates a clinical development bridge to India, offers end-to-end services to customers, including CRO selection for a specific clinical program, monitoring of clinical studies, auditing, quality assurance, design and conduct of Phase I-IV studies, in-country sponsor representation, medical writing, and regulatory support. "CROs from the USA can benefit from this relationship due to fast recruitment, good quality, and cost effectiveness," said Dr. Emran Khan, Director of Abridge. "We are delighted to be working with GPSI in the offering of these services." GPSI will be the point of contact for U.S. businesses who are interested in conducting clinical studies in India.
|
Featured Jobs |